Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India

Journal of the Indian Medical Association

Volumn 101, Issue 2, 2003, Pages

  Sonawalla, Shamsah ^a   Chakraborty, Nabonita ^b   Parikii, Rajesh ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hergest Unit   (United Kingdom)

^c JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Antidepressant; Anxiety; Depression; Tianeptine

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; THIAZEPINE DERIVATIVE;

ANXIETY DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART FUNCTION; HEMODYNAMICS; HUMAN; INDIA; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; OUTPATIENT CARE; PATIENT COMPLIANCE; RATING SCALE; RESTLESSNESS; VOMITING; ADULT; AGED; AMBULATORY CARE; ARTICLE; DEPRESSION; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; THIAZEPINES;

EID: 0041767280     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Kessler RC, MacGonaghe KA, Zhao S, et al - Lifetime and 12-month prevalence of DSM III R psychiatric disorders in the United States: results from the National Comorbidity survey. Arch Gen Psychiatry 1994; 51: 8-19.
2. Harrison G - New or old antidepressants? New is better. BMJ 1994; 309: 1280-2.
3. Michels R, Marzuk PM - Progress in psychiatry. N Engl J Med 1993; 329: 628-38.
4. Davis R, Wilde MI - Sertraline: a pharmacoeconomic evaluation of its use in depression. Pharmacoeconomics 1996; 10: 409-31.
5. Song F, Freemantle N, Sheldon T, et al - Selective serotonin reuptake inhibitors: meta analysis of efficacy and acceptability. BMJ 1993; 306: 683-7.
6. Kato G, Weitsch AF - Neurochemical profile of tianeptine, a new antidepressant drug. Clin Neuropharmacology 1988; 11: S43-S50.
7. Costa e Silva JA, Ruschel SI, Caetano D, et al - Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology 1997; 35: 24-9.
8. Cassano GB, Heinze G, Lôo H - A double blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes. Eur Psychiatry 1996; 11: 254-9.
9. Invernizzi G, Aguglia E, Bertolino A - The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double blind multicentre study versus amitriptyline. Neuropsychobiology 1994; 30: 85-93.
10. Alby JM, Ferreri M, Cabanne J - Efficacy of tianeptine for treatment of major depression and dysthymia with somatic complaints: a comparative study versus fluoxetine. Ann Psychiatrie 1993; 8: 136-44.
11. Simon G, Wagner E, Vonkorff M - Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol 1995; 48: 363-73.
12. Potter WZ, Rudorfer W, Manji H - The pharmacologic treatment of depression. N Engl J Med 1991; 325: 633-42.